ESSENTIAL FUNCTIONS AND RESPONSIBILITIES
- Lead annual operating plans, rolling forecasts, and long‑range plans for clinical functions (including Regulatory and Quality).
- Develop and maintain clinical trial budgets, enrollment‑based forecasts, and scenario models (including timeline shifts, protocol amendments, and vendor changes).
- Partner with CMO and clinical operations to monitor trial spend, burn rates, and forecasts by identifying risks, opportunities, and mitigation strategies.
- Support portfolio prioritization and investment decisions, translating clinical strategy into clear financial implications.
- Act as system owner and administrator for Adaptive Insights, including model design, data governance, integration, user access, and reporting standards.
- Build and maintain scalable financial models to support clinical programs, headcount, vendor spend, and long‑term planning.
- Partner with IT, Accounting, and FP&A stakeholders to ensure data accuracy, system controls, and audit readiness.
- Lead enhancements and continuous improvement initiatives as Janux grows, ensuring the system supports evolving business needs.
- Review and interpret PO workbooks, vendor commitments, and accrual schedules to ensure forecasts align with actual obligations.
- Help bridge FP&A forecasts with GAAP results, supporting variance analysis and management reporting.
- Present financial insights and recommendations to senior leadership in a clear, concise, and decision‑oriented manner.
- Contribute to building best‑in‑class finance processes in a fast‑growing clinical‑stage biotech environment.
- Perform other duties as deemed necessary.
EDUCATION, EXPERIENCE, KNOWLEDGE, SKILLS, AND ABILITIES
- Bachelor’s degree in Finance, Accounting, Economics, or related field.
- 8–12+ years of FP&A experience, with significant exposure to biotech, pharma, or life sciences.
- Hands‑on experience administering Adaptive Insights (or similar FP&A systems).
- Strong understanding of clinical trial budgeting, forecasting, and accrual concepts.
- Advanced Excel and financial modeling skills.
- Ability to operate effectively in a fast‑paced, evolving clinical‑stage company.
- Experience supporting oncology or clinical-stage programs is highly desirable.
- Prior accounting experience a plus.
Top Skills
What We Do
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
